2025
SJR Q1
JCR Q1 · 5,3
114 matched articles
SCIE
Journal detail
Lung Cancer
- Publisher
- Elsevier Ireland Ltd
- Country
- Ireland · Western Europe
- Type
- journal
- ISSN
-
0169500218728332
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,928
- Quartile Q1
- H-Index 160
- Cites/doc 4,93
- Docs (3y) 678
- Cites (3y) 3.439
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 5,3
- 5Y JIF 5,1
- JCI 1,15
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cancer Research Q1
- Oncology Q1
- Pulmonary and Respiratory Medicine Q1
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Oncology | Respiratory System
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,928 | 5,3 | 5,1 | 1,15 | Q1 | 160 |
| 2024 | Q1 | Q1 | 1,752 | 4,4 | 4,5 | 1,1 | Q1 | 154 |
| 2023 | Q1 | Q1 | 1,761 | 4,5 | 4,7 | 1,12 | Q1 | 154 |
| 2022 | Q1 | Q2 | 1,609 | 5,3 | 5,6 | 1,17 | Q1 | 154 |
| 2021 | Q1 | Q1 | 1,399 | 6,1 | 5,9 | 1,19 | Q1 | 154 |
| 2020 | Q1 | Q1 | 1,989 | 5,7 | 5,6 | 1,26 | Q1 | 154 |
| 2019 | Q1 | Q1 | 1,705 | 4,7 | 4,6 | 1,24 | Q1 | 154 |
| 2018 | — | Q1 | — | 4,6 | 4,4 | 1,24 | Q1 | — |
| 2017 | Q1 | Q1 | 1,75 | 4,5 | 4,4 | 1,2 | Q1 | 154 |
| 2016 | Q1 | Q1 | 1,703 | 4,3 | 4,2 | — | — | 154 |
| 2015 | Q1 | Q1 | 1,885 | 3,8 | 3,8 | — | — | 154 |
| 2014 | Q1 | Q1 | 1,764 | 4 | 3,7 | — | — | 154 |
| 2013 | Q1 | Q1 | 1,672 | 3,7 | 3,6 | — | — | 154 |
| 2012 | Q1 | Q1 | 1,472 | 3,4 | 3,5 | — | — | 154 |
| 2011 | Q1 | Q1 | 1,572 | 3,4 | 3,2 | — | — | 154 |
| 2010 | Q1 | Q1 | 1,394 | 3,4 | 3,3 | — | — | 154 |
| 2009 | — | Q1 | — | 3,1 | 3,2 | — | — | — |
| 2008 | — | Q2 | — | 3 | 3 | — | — | — |
| 2007 | — | Q1 | — | 3,5 | 3,1 | — | — | — |
| 2006 | — | Q1 | — | 3,6 | — | — | — | — |
| 2005 | — | Q2 | — | 3,2 | — | — | — | — |
| 2004 | — | Q2 | — | 2,9 | — | — | — | — |
| 2003 | — | Q2 | — | 1,8 | — | — | — | — |
| 2002 | — | Q2 | — | 2,5 | — | — | — | — |
| 2001 | — | Q1 | — | 2,9 | — | — | — | — |
| 2000 | — | Q3 | — | 1,4 | — | — | — | — |
| 1999 | — | Q2 | — | 1,9 | — | — | — | — |
| 1998 | — | Q2 | — | 1,9 | — | — | — | — |
| 1997 | — | Q2 | — | 1,1 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ONCOLOGY | SCIE | Q1 | Q1 | 80/333 |
| 2025 | RESPIRATORY SYSTEM | SCIE | Q1 | Q1 | 16/107 |
| 2024 | ONCOLOGY | SCIE | Q2 | Q1 | 85/328 |
| 2024 | RESPIRATORY SYSTEM | SCIE | Q1 | Q1 | 19/108 |
| 2023 | ONCOLOGY | SCIE | Q1 | Q1 | 78/322 |
| 2023 | RESPIRATORY SYSTEM | SCIE | Q1 | Q1 | 20/101 |
| 2022 | ONCOLOGY | SCIE | Q2 | Q1 | 70/241 |
| 2022 | RESPIRATORY SYSTEM | SCIE | Q2 | Q1 | 18/66 |
| 2021 | ONCOLOGY | SCIE | Q2 | Q1 | 67/245 |
| 2021 | RESPIRATORY SYSTEM | SCIE | Q1 | Q1 | 16/66 |
| 2020 | ONCOLOGY | SCIE | Q2 | Q1 | 73/242 |
| 2020 | RESPIRATORY SYSTEM | SCIE | Q1 | Q1 | 13/64 |
| 2019 | ONCOLOGY | SCIE | Q2 | Q1 | 72/244 |
| 2019 | RESPIRATORY SYSTEM | SCIE | Q1 | Q1 | 15/64 |
| 2018 | ONCOLOGY | SCIE | Q2 | Q1 | 64/230 |
| 2018 | RESPIRATORY SYSTEM | SCIE | Q1 | Q1 | 12/63 |
| 2017 | ONCOLOGY | SCIE | Q2 | Q1 | 64/223 |
| 2017 | RESPIRATORY SYSTEM | SCIE | Q1 | Q1 | 9/60 |
| 2016 | ONCOLOGY | SCIE | Q2 | — | 59/217 |
| 2016 | RESPIRATORY SYSTEM | SCIE | Q1 | — | 11/59 |
| 2015 | ONCOLOGY | SCIE | Q2 | — | 65/213 |
| 2015 | RESPIRATORY SYSTEM | SCIE | Q1 | — | 12/58 |
| 2014 | ONCOLOGY | SCIE | Q2 | — | 59/211 |
| 2014 | RESPIRATORY SYSTEM | SCIE | Q1 | — | 12/58 |
| 2013 | ONCOLOGY | SCIE | Q2 | — | 61/203 |
| 2013 | RESPIRATORY SYSTEM | SCIE | Q1 | — | 11/54 |
| 2012 | ONCOLOGY | SCIE | Q2 | — | 72/197 |
| 2012 | RESPIRATORY SYSTEM | SCIE | Q1 | — | 12/50 |
| 2011 | ONCOLOGY | SCIE | Q2 | — | 62/196 |
| 2011 | RESPIRATORY SYSTEM | SCIE | Q1 | — | 11/48 |
| 2010 | ONCOLOGY | SCIE | Q2 | — | 61/185 |
| 2010 | RESPIRATORY SYSTEM | SCIE | Q1 | — | 11/46 |
| 2009 | ONCOLOGY | SCIE | Q2 | — | 62/166 |
| 2009 | RESPIRATORY SYSTEM | SCIE | Q1 | — | 10/43 |
| 2008 | ONCOLOGY | SCIE | Q2 | — | 63/143 |
| 2008 | RESPIRATORY SYSTEM | SCIE | Q2 | — | 11/40 |
| 2007 | ONCOLOGY | SCIE | Q2 | — | 48/132 |
| 2007 | RESPIRATORY SYSTEM | SCIE | Q1 | — | 8/34 |
| 2006 | ONCOLOGY | SCIE | Q2 | — | 46/127 |
| 2006 | RESPIRATORY SYSTEM | SCIE | Q1 | — | 8/34 |
| 2005 | ONCOLOGY | SCIE | Q2 | — | 49/123 |
| 2005 | RESPIRATORY SYSTEM | SCIE | Q2 | — | 9/33 |
| 2004 | ONCOLOGY | SCIE | Q2 | — | 50/123 |
| 2004 | RESPIRATORY SYSTEM | SCIE | Q2 | — | 9/33 |
| 2003 | ONCOLOGY | SCIE | Q3 | — | 76/120 |
| 2003 | RESPIRATORY SYSTEM | SCIE | Q2 | — | 15/31 |
| 2002 | ONCOLOGY | SCIE | Q2 | — | 43/114 |
| 2002 | RESPIRATORY SYSTEM | SCIE | Q2 | — | 9/32 |
| 2001 | ONCOLOGY | SCIE | Q2 | — | 31/107 |
| 2001 | RESPIRATORY SYSTEM | SCIE | Q1 | — | 6/30 |
| 2000 | ONCOLOGY | SCIE | Q3 | — | 62/103 |
| 2000 | RESPIRATORY SYSTEM | SCIE | Q3 | — | 18/29 |
| 1999 | ONCOLOGY | SCIE | Q2 | — | 41/105 |
| 1999 | RESPIRATORY SYSTEM | SCIE | Q2 | — | 12/30 |
| 1998 | ONCOLOGY | SCIE | Q2 | — | 38/104 |
| 1998 | RESPIRATORY SYSTEM | SCIE | Q2 | — | 9/29 |
| 1997 | ONCOLOGY | SCIE | Q3 | — | 56/102 |
| 1997 | RESPIRATORY SYSTEM | SCIE | Q2 | — | 10/23 |